World's Best Scientists 2026 revealed!
Evanthia Galanis

Evanthia Galanis

D-Index & Metrics

Medicine

D-Index
83
Citations
30285
World Ranking
15463
National Ranking
7799

Overview

Evanthia Galanis is affiliated with the Mayo Clinic in the United States and has a research focus primarily within the field of Medicine. Their work spans several interrelated subfields, including Genetics, Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, and Epidemiology.

The scientist's research topics prominently cover:

  • Glioma Diagnosis and Treatment
  • Brain Metastases and Treatment
  • Cancer Genomics and Diagnostics
  • Meningioma and schwannoma management
  • Virus-based gene therapy research
  • Medical Imaging Techniques and Applications
  • CAR-T cell therapy research

Among their recent publications are:

  • "Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions," 2020, Neuro-Oncology
  • "RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults," 2023, Journal of Clinical Oncology
  • "Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases," 2020, Neuro-Oncology
  • "Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas," 2020, Neuro-Oncology
  • "Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement," 2021, Clinical Cancer Research

The scientist frequently publishes in the following venues:

  • Neuro-Oncology
  • Journal of Clinical Oncology
  • Neuro-Oncology Advances
  • Nature Medicine
  • JAMA Oncology

Collaborations have been established with several co-authors, including:

  • Patrick Y. Wen
  • Michael Weller
  • David A. Reardon
  • Priscilla K. Brastianos
  • Timothy J. Kaufmann

Best Publications

  • Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

    Patrick Y. Wen;David R. Macdonald;David A. Reardon;Timothy F. Cloughesy

  • Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial

    Paul D. Brown;Kurt Jaeckle;Karla V. Ballman;Elana Farace

  • Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial

    Paul D. Brown;Paul D. Brown;Karla V. Ballman;Karla V. Ballman;Jane H. Cerhan;S. Keith Anderson

  • Phase II Trial of Temsirolimus (CCI-779) in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

    Evanthia Galanis;Jan C. Buckner;Matthew J. Maurer;Jeffrey I. Kreisberg

  • Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions

    Patrick Y. Wen;Michael Weller;Eudocia Quant Lee;Brian M. Alexander

  • Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials

    Benjamin M. Ellingson;Martin Bendszus;Martin Bendszus;Jerrold Boxerman;Daniel Barboriak

  • Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress.

    Ta Chiang Liu;Evanthia Galanis;David Kirn

  • Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data.

    Jann N Sarkaria;Leland S Hu;Ian F Parney;Deanna H Pafundi

  • Targeting angiogenesis: progress with anti-VEGF treatment with large molecules.

    Axel Grothey;Evanthia Galanis

  • Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

    Evanthia Galanis;Kurt A. Jaeckle;Matthew J. Maurer;Joel M. Reid

  • Chapter 23 - Glioblastoma

    Hans-Georg Wirsching;Evanthia Galanis;Michael Weller

  • Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme.

    Caterina Giannini;Jann N. Sarkaria;Atsushi Saito;Joon H. Uhm

  • Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer

    Evanthia Galanis;Lynn C. Hartmann;William A. Cliby;Harry J. Long

  • Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial.

    T Reid;E Galanis;J Abbruzzese;D Sze

  • Use of a Vaccine Strain of Measles Virus Genetically Engineered to Produce Carcinoembryonic Antigen as a Novel Therapeutic Agent against Glioblastoma Multiforme

    Loi K. Phuong;Cory Allen;Kah Whye Peng;Caterina Giannini

  • Intraperitoneal Therapy of Ovarian Cancer Using an Engineered Measles Virus

    Kah Whye Peng;Cynthia J. TenEyck;Evanthia Galanis;Kimberly R. Kalli

  • Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study.

    Bret B. Friday;S. Keith Anderson;Jan Buckner;Chunrong Yu

  • Mesenchymal Stem Cell Carriers Protect Oncolytic Measles Viruses from Antibody Neutralization in an Orthotopic Ovarian Cancer Therapy Model

    Emily K. Mader;Yoshihiro Maeyama;Yi Lin;Greg W. Butler

  • Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results

    Evanthia Galanis;Jan C. Buckner;Robert P. Dinapoli;Bernd W. Scheithauer

  • Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel

    Jann N. Sarkaria;Lin Yang;Patrick T. Grogan;Gaspar J. Kitange

Frequent Co-Authors

Jan C. Buckner
Jan C. Buckner Mayo Clinic
Patrick Y. Wen
Patrick Y. Wen Harvard University
Paul D. Brown
Paul D. Brown Mayo Clinic
Jann N. Sarkaria
Jann N. Sarkaria Mayo Clinic
David A. Reardon
David A. Reardon Harvard University
Karla V. Ballman
Karla V. Ballman Cornell University
Susan M. Chang
Susan M. Chang University of California, San Francisco
Martin J. van den Bent
Martin J. van den Bent Erasmus University Rotterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative healthcare careers can be a smart move for those interested in Medicine but seeking different education pathways or quicker entry into the field. For instance, direct admit nursing programs offer a streamlined route for aspiring nurses by allowing students to enter nursing school immediately after high school without additional prerequisites.

If you prefer administrative roles, consider medical billing and coding schools online with financial aid. These programs prepare students for essential behind-the-scenes work and often provide flexible, affordable online options.

For those seeking a faster path into nursing, accredited lpn program no entrance exam options can help you start your healthcare journey without standardized testing barriers. This makes the process more accessible for many students.

Lastly, a degree in healthcare administration opens doors to leadership and management roles in clinics, hospitals, and other healthcare facilities. Accelerated online programs are available for those eager to advance their careers quickly.

Best Scientists Citing Evanthia Galanis

Trending Scientists